Crimean-Congo hemorrhagic fever orthonairovirus Nucleocapsid Protein polyclonal antibody, Unconjugated, Rabbit

Artikelnummer: BWT-NCP0461P
Artikelname: Crimean-Congo hemorrhagic fever orthonairovirus Nucleocapsid Protein polyclonal antibody, Unconjugated, Rabbit
Artikelnummer: BWT-NCP0461P
Hersteller Artikelnummer: NCP0461P
Alternativnummer: BWT-NCP0461P-50UL,BWT-NCP0461P-100UL
Hersteller: Bioworld Technology
Wirt: Rabbit
Kategorie: Antikörper
Applikation: ELISA, WB
Immunogen: Recombinant protein of CCHFV-NP.
Konjugation: Unconjugated
Crimean-Congo hemorrhagic fever (CCHF) is caused by infection with a tick-borne virus (Nairovirus) in the family Bunyaviridae. The disease was first characterized in the Crimea in 1944 and given the name Crimean hemorrhagic fever. It was then later recognized in 1969 as the cause of illness in the Congo, thus resulting in the current name of the disease.Crimean-Congo hemorrhagic fever (CCHF) is caused by infection with a tick-borne virus (Nairovirus) in the family Bunyaviridae. The disease was first characterized in the Crimea in 1944 and given the name Crimean hemorrhagic fever. It was then later recognized in 1969 as the cause of illness in the Congo, thus resulting in the current name of the disease.Crimean-Congo hemorrhagic fever is found in Eastern Europe, particularly in the former Soviet Union, throughout the Mediterranean, in northwestern China, central Asia, southern Europe, Africa, the Middle East, and the Indian subcontinent.
UniProt: NM_001313894.1
Reinheit: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Formulierung: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2.
Application Verdünnung: WB: 1:500~1:2000 ELISA: 1:5000~10000
Anwendungsbeschreibung: Crimean-Congo hemorrhagic fever orthonairovirus Nucleocapsid Protein polyclonal antibody detects endogenous levels of CCHFV-NP protein.